FTC Defeats Another Hospital Merger

by Baker Donelson
Contact

The Federal Trade Commission’s (FTC) recent streak of successfully challenging hospital mergers under section 7 of the Clayton Act (15 U.S.C. § 18) continues. On April 22, 2014, the United States Court of Appeals for the Sixth Circuit denied a petition filed by ProMedica Health System, Inc. (ProMedica) challenging the FTC’s final Order requiring ProMedica to divest itself of St. Luke’s Hospital (St. Luke’s). ProMedica Health System, Inc. v. Federal Trade Commission, 2014 WL 1584835 (6th Cir. April 22, 2014).

ProMedica and St. Luke’s are two of four hospitals located in Lucas County, Ohio. According to the court’s opinion, ProMedica is the largest and “most dominant” provider in Lucas County with a 46.8 percent share of the general acute care cluster market (GAC). St. Luke’s, on the other hand, is the smallest hospital provider in Lucas County with a GAC market share of approximately 11.5 percent. St. Luke’s offers only primary and secondary care services, and does not have an obstetrics department. The other two hospital providers in Lucas County are Mercy Health Partners with a 28.7 percent market share, and the University Of Toledo Medical Center with 13 percent share.

The parties agreed to, and the court accepted, a geographic market for antitrust purposes that was limited to Lucas County. However, the appropriate definition of the relevant product market was disputed, with ProMedica arguing that the FTC erred by limiting the cluster market to primary and secondary services. The court discussed the appropriate framework for analyzing and defining the relevant product market, using the Horizontal Merger Guidelines (Merger Guidelines) as guidance (after pointing out that they were not binding on the court). After which, the court concluded that the FTC had conducted the appropriate analysis and produced sufficient evidence to support a finding of two separate relevant product markets, one consisting of a GAC limited to primary and secondary services, and a second limited to just obstetrics services. The court’s decision was aided by ProMedica’s concession, made in its pleadings, agreeing that tertiary services were not in the relevant market. The court went on to accept the FTC’s evidence demonstrating that a merged entity would garner a 60 percent share of the GAC market, and an even larger 80 percent share of the obstetrics market.

In addition, and despite acknowledging that the tool used by the FTC to measure market concentration (i.e., the Herfindahl-Hirschman Index (HHI)) was perhaps not appropriate in a case limited to a unilateral effects analysis (anticompetitive effects due to the elimination of competition between the merging entities), the court nevertheless refused to ignore what it described as exceptionally high HHI numbers that, under the Merger Guidelines, created a rebuttable presumption of illegality. The court noted the strong correlation between market share and the ability to raise prices, and indicated that ProMedica’s high market share in what was already a concentrated market would grow after the merger and at some point the FTC was entitled to put significant weight in the market concentration data.

Additional evidence presented by the FTC convinced the court that the FTC correctly found that the merger would adversely affect competition in violation of section 7. The court looked at, among other things, historical evidence from managed care organizations (MCO), and e-mails from the parties themselves, identifying each other as their closest competitors. MCOs testified that they could not successfully market a plan that did not include at least one of the merging parties, but had successfully marketed plans that included only one rather than both of the parties. ProMedica also provided discounts (albeit small) to MCOs that excluded St. Luke’s, and internal e-mails from St. Luke’s management (namely its turnaround specialist) noted that ProMedica was its “most significant competitor,” and indicated that a merger with ProMedica “ha[s] the greatest potential for higher hospital rates … [and] a lot of negotiating clout.”

Finally, the court concluded that ProMedica made little effort to rebut the presumption of illegality. For starters, ProMedica made no effort to show that the transaction would benefit consumers (through efficiencies or otherwise) rather than just benefit the parties. Apparently, quality considerations were not a driving factor as St. Luke’s quality actually exceeded ProMedica’s. The court also stated that ProMedica’s “weakened competitor” defense based on St. Luke’s dire financial straits (in an effort to show that St. Luke’s offered no real competitive constraint to ProMedica) was easily rejected due to the fact that St. Luke’s market share had actually been increasing prior to the merger.

The ProMedica decision further highlights a number of continuing themes that seem to undermine difficult hospital transactions. First, in-depth and early consideration should be given to the consumer benefits expected from the transaction. As noted by the court, the greater the potential for anticompetitive harm, the greater must be the offsetting consumer benefits. Second, create an action plan, early in the transaction process, for reaching out to relevant third parties (primarily MCOs) and community members to garner support for the transaction. And, finally, train employees (particularly those involved in strategic planning, negotiating, and marketing) how not to crater a transaction before it starts by understanding what should and should not appear in print.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Baker Donelson | Attorney Advertising

Written by:

Baker Donelson
Contact
more
less

Baker Donelson on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.